Bangkok
Bangkok
Bangkok, Pathumwan, Thailand13 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Active, not recruiting | Phase 3 | 2026-07-17 | NCT04603495 | |
| The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1 | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, cardio-renal syndrome, cardiovascular disorder, heart disorder, heart failure, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 2 / Phase 3 | 2026-06-16 | NCT06030843 | |
| Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 2 | 2026-06-02 | NCT05383742 | |
| Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER) | HIV Prevention; HIV Related Stigma; PrEP Adherence | Recruiting | Not applicable | 2026-04-03 | NCT07509827 | |
| LA PrEP Impact and Cost-effectiveness (TEAMS) | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-03-18 | NCT05774548 | |
| Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Early phase 1 | 2026-03-09 | NCT07458659 | |
| Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL) | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Recruiting | Phase 1 | 2026-03-02 | NCT07078929 | |
| Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors | Pediatric Cancers; Solid Tumor Pediatric | Recruiting | Phase 1 | 2026-03-02 | NCT06612645 | |
| Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Not applicable | 2025-09-25 | NCT07067229 | |
| Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain disorder, brainstem cancer, central nervous system cancer, central nervous system disorder, diffuse intrinsic pontine glioma, epithelial neoplasm, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2025-03-30 | NCT06221553 | |
| Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men | Drug Interaction | Active, not recruiting | Not applicable | 2024-11-25 | NCT04593680 | |
| Assessment of Drug-drug Interactions Between Feminizing Hormone Therapy and Emtricitabine/Tenofovir Alafenamide Concomitantly for Pre-exposure Prophylaxis Among Transgender Women | Drug Interaction | Active, not recruiting | Not applicable | 2024-11-25 | NCT04590417 | |
| Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic | HIV Prevention | Enrolling by invitation | Not stated | 2024-11-25 | NCT02437981 |